AssetMark Inc’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

AssetMark Inc’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-123	Closed	-$5K	–	1609
2021 Q1	$5K	Buy	+123	New	+$3.07K	﹤0.01%	1031
2018 Q3	–	Sell	-18	Closed	–	–	1486
2018 Q2	$0	Hold	18	–	–	﹤0.01%	1486
2018 Q1	$0	Hold	18	–	–	﹤0.01%	2150
2017 Q4	$0	Hold	18	–	–	﹤0.01%	2218
2017 Q3	$1K	Hold	18	–	–	﹤0.01%	1434
2017 Q2	$1K	Hold	18	–	–	﹤0.01%	1346
2017 Q1	$1K	Hold	18	–	–	﹤0.01%	1240
2016 Q4	$1K	Hold	18	–	–	﹤0.01%	1220
2016 Q3	$1K	Hold	18	–	–	﹤0.01%	1191
2016 Q2	$1K	Buy	+18	New	+$783	﹤0.01%	1151

AssetMark Inc's FPRX Position: Q2 2021 in Review

AssetMark Inc sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 123 shares — an estimated $5K sold.

AssetMark Inc first reported a position in FPRX in Q2 2016 and held it in 10 quarters. The position peaked at $5K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

AssetMark Inc reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
AssetMark Inc sold 123 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $5K.
AssetMark Inc first reported a position in Five Prime Therapeutics, Inc. in Q2 2016 and held it in 10 quarters.
AssetMark Inc's Five Prime Therapeutics, Inc. position peaked at $5K in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on AssetMark Inc's 13F filing for Q2 2021, filed 16 Aug 2021.